CURO Group Holdings Corp. Receives Continued Listing Standard Notice From the NYSE
30 Outubro 2023 - 5:30PM
Business Wire
CURO Group Holdings Corp. (NYSE:CURO) today announced that on
October 27, 2023, it received notice (the “Notice”) from the New
York Stock Exchange (NYSE) that it is no longer in compliance with
the NYSE continued listing standards set forth in Section 802.01C
of the NYSE’s Listed Company Manual due to the fact that the
average closing price of the Company’s common stock, par value
$0.10 per share (the “Common Stock”), over the prior 30 consecutive
trading days was below $1.00 per share.
The Notice does not affect the Company’s business operations or
its reporting obligations with the Securities and Exchange
Commission, and it does not conflict with or cause an event of
default under any of the Company’s material debt or other
agreements.
As required by the NYSE, the Company plans to notify the NYSE of
its intent to cure the price deficiency and restore its compliance
with Section 802.01C of the NYSE continued listing standards. The
Company has a period of six months following the receipt of the
Notice to regain compliance. As a result, the Company has until
April 27, 2024 to regain compliance. If the Company determines that
in order to cure the price condition it is necessary to take an
action that requires shareholder approval, it must obtain
shareholder approval by no later than its 2024 annual meeting and
must implement the action promptly thereafter. To regain
compliance, on the last trading day in any calendar month, the
Common Stock must have (i) a closing price of at least $1.00 per
share and (ii) an average closing price of at least $1.00 per share
over the 30 consecutive trading-day period ending on the last
trading day of such month. If the Company is unable to regain
compliance, the NYSE will initiate procedures to suspend and delist
the Common Stock.
The Notice has no immediate impact on the listing of the
Company’s common stock, which will continue to be listed and traded
on the NYSE during the cure period under the common stock trading
symbol “CURO”, subject to the Company’s continued compliance with
the other listing requirements of the NYSE. However, the common
stock trading symbol will have an added designation of “.BC” to
indicate that the status of the common stock is “below compliance”
with the NYSE continued listing standards. The “.BC” indicator will
be removed at such time as the Company regains compliance.
Cautionary Note Regarding Forward-Looking Statements
This press release contains, and oral statements made from time
to time by our representatives may contain, “forward-looking
statements.” Forward-looking statements include statements
identified by words such as “could,” “may,” “might,” “will,”
“intends,” “plans,” “seeks,” “believes,” “estimates,” “expects,”
“continues,” “projects” and similar references to future periods,
or by the inclusion of forecasts or projections. Forward-looking
statements are based on our current expectations and assumptions
regarding capital market conditions, our business, the economy and
other future conditions. Because forward-looking statements relate
to the future, by their nature, they are subject to inherent
uncertainties, risks and changes in circumstances that are
difficult to predict. As a result, our actual results may differ
materially from those contemplated by the forward-looking
statements. Important factors that could cause actual results to
differ materially from those in the forward-looking statements
include, but are not limited to, our ability to regain compliance
with the continued listing criteria of the NYSE within the
available cure period; risks arising from the potential suspension
of trading of our common stock on the NYSE; regional, national or
global political, economic, business, competitive, market and
regulatory conditions, including risks regarding our ability to
manage inventory or anticipate consumer demand; changes in consumer
confidence and spending; our competitive environment; our failure
to open new profitable stores or successfully enter new markets and
other factors set forth under “Risk Factors” in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2022 as updated
by our Quarterly Report on Form 10-Q for the quarter ended March
31, 2023. Any forward-looking statement made in this report speaks
only as of the date on which it is made. The Company undertakes no
obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future
developments or otherwise.
(CURO-NWS)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231030930724/en/
Investor Relations:
Email: IR@curo.com
CURO (NYSE:CURO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
CURO (NYSE:CURO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024